Contact Us
Anti-D Immunoglobulin Global Market Report 2025
Global Anti-D Immunoglobulin Market Report 2025
Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Anti-D Immunoglobulin Global Market Report 2025

By Product Type (Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel), By Application (Hemolytic Disease Of The Newborn, Immune Thrombocytopenic Purpura, Antenatal And Postnatal Prophylaxis, Other Applications), By End-User (Hospitals, Clinics, Blood Banks, Research Laboratories) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Anti-D Immunoglobulin Market Overview

• Anti-D Immunoglobulin market size has reached to $2.42 billion in 2024

• Expected to grow to $3.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%

• Growth Driver: Rise In Global Birth Rates Fueling The Growth Of The Market Due To Increasing Risk Of Rh Incompatibility

• Market Trend: Recombinant Innovation Enhances Rh Prophylaxis And Maternal Health Outcomes Globally

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anti-D Immunoglobulin Market?

Anti-D immunoglobulin is a specialized blood product derived from human plasma that contains antibodies against the RhD antigen found on red blood cells. It is produced by collecting plasma from donors who have been sensitized to the RhD antigen, followed by purification and concentration of the specific immunoglobulin G (IgG) antibodies.

The main product types of anti-D immunoglobulin are intramuscular anti-D immunoglobulin and intravenous anti-D immunoglobulin. Intramuscular anti-D immunoglobulin is a plasma-derived antibody preparation administered into muscle tissue to prevent Rh incompatibility in Rh-negative individuals by neutralizing Rh-positive fetal red blood cells. These are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others, and are used in various applications such as hemolytic disease of the newborn, immune thrombocytopenic purpura, antenatal and postnatal prophylaxis, and others. It is used by several end-users, such as Hospitals, clinics, blood banks, and research laboratories.

Anti-D Immunoglobulin Market Size and growth rate 2025 to 2029: Graph

What Is The Anti-D Immunoglobulin Market Size 2025 And Growth Rate?

The anti-D immunoglobulin market size has grown strongly in recent years. It will grow from $2.42 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing awareness of rhesus incompatibility risks, expanding national immunization programs, implementation of maternal and neonatal health policies, rising global birth rates, and growth in blood transfusion procedures.

What Is The Anti-D Immunoglobulin Market Growth Forecast?

The anti-D immunoglobulin market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising demand for antenatal and perinatal care, growing emphasis on maternal health in low- and middle-income countries, increasing healthcare infrastructure investments, expansion of universal health coverage programs, and regulatory support for immunoglobulin therapies. Major trends in the forecast period include advancements in plasma fractionation technology, development of recombinant antibody alternatives, increasing automation in immunoglobulin production, adoption of high-purity formulation techniques, and integration of cold chain monitoring systems.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Anti-D Immunoglobulin Market Segmented?

1) By Product Type: Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel

3) By Application: Hemolytic Disease Of The Newborn, Immune Thrombocytopenic Purpura, Antenatal And Postnatal Prophylaxis, Other Applications

4) By End-User: Hospitals, Clinics, Blood Banks, Research Laboratories

Subsegments:

1) By Intramuscular Anti-D Immunoglobulin: Standard Dose, High Dose, Pre-Filled Syringes, Vials

2) By Intravenous Anti-D Immunoglobulin: Lyophilized Powder, Liquid Formulation, Single-Use Vials, Multi-Dose Vials

What Is Driving The Anti-D Immunoglobulin Market? Rise In Global Birth Rates Fueling The Growth Of The Market Due To Increasing Risk Of Rh Incompatibility

The high birth rates are expected to propel the growth of the anti-D immunoglobulin market going forward. Birth rates represent the number of live births recorded annually for every 1,000 people in a population. Birth rates are increasing due to insufficient access to education and family planning services, resulting in higher fertility and larger families. Anti-D immunoglobulin helps birth rates by preventing Rh incompatibility in pregnancy, which reduces the risk of hemolytic disease in newborns and supports healthier outcomes in future pregnancies. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, there were 3,622,673 recorded births in 2024, reflecting a 1% increase from the previous year. Therefore, the high birth rates are driving the growth of the anti-D immunoglobulin market.

What Is Driving The Anti-D Immunoglobulin Market? Expansion Of Healthcare Infrastructure Fueling The Growth Of The Market Due To Improved Access To Maternal Care Services

The expanding healthcare infrastructure is expected to propel the growth of the anti-D immunoglobulin market going forward. Healthcare infrastructure refers to the system of facilities, equipment, workforce, and support mechanisms essential for delivering healthcare services within a population. Healthcare infrastructure is expanding as a result of the growing global population, which drives higher demand for medical care and necessitates the development of more hospitals, clinics, and related resources. Healthcare infrastructure expansion enhances access to maternal healthcare, enabling better screening and timely use of anti-D immunoglobulin to prevent hemolytic disease in newborns. For instance, in May 2023, according to the Department of Health and Social Care, a UK-based government department, the government announced plans to allocate more than $27 billion (£20 billion) toward building new hospital facilities. As part of the New Hospital Programme, two hospitals are already finished, five are currently being built, and over 20 are set to be underway or completed by the end of the following year. Therefore, the expanding healthcare infrastructure is driving the growth of the anti-D immunoglobulin market.

Who Are The Major Players In The Global Anti-D Immunoglobulin Market?

Major companies operating in the anti-d immunoglobulin market are Merck Group, Bayer AG, CSL Behring, Baxter International Inc., Intas Pharmaceuticals Ltd., Octapharma AG, Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kedrion Biopharma Inc., Biotest AG, Sanquin, Taj Pharmaceuticals Limited, Kamada Pharmaceuticals, Bharat Serums and Vaccines Limited, Saol Therapeutics Inc., Aetos Pharma Private Limited, Avin Darou, PV Pharma Healthcare Pvt. Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Ocean Pharmacoat Pvt. Ltd.

What Are The Key Trends Of The Global Anti-D Immunoglobulin Market? Recombinant Innovation Enhances Rh Prophylaxis And Maternal Health Outcomes Globally

Major companies operating in the anti-D immunoglobulin market are focusing on developing innovative solutions such as recombinant anti-D immunoglobulin to expand access to safe and reliable prophylaxis for Rh-negative pregnant individuals and improve maternal outcomes. A recombinant anti-D immunoglobulin is a lab-engineered monoclonal antibody designed to prevent Rh incompatibility in Rh-negative individuals, offering an alternative to plasma-derived anti-D therapies with enhanced consistency, safety, and scalability. For instance, in January 2022, Bharat Serums and Vaccines (BSV), an India-based biopharmaceutical company, launched the world’s first marketed recombinant anti-Rho (D) immunoglobulin. The product introduces a scientifically advanced approach to Rh prophylaxis by utilizing recombinant technology, which enhances product reliability and minimizes variability associated with plasma-derived alternatives. Its availability is particularly significant in regions with high numbers of Rh-negative pregnancies, where it can improve preventive care and reduce the risk of hemolytic disease in newborns.

Need data on a specific region in this market?

What Is The Regional Outlook For The Global Anti-D Immunoglobulin Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Anti-D Immunoglobulin Industry?

The anti-D immunoglobulin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including anti-D immunoglobulin industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anti-D immunoglobulin industry. This anti-D immunoglobulin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Anti D Immunoglobulin Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.59 billion
Revenue Forecast In 2034 $3.34 billion
Growth Rate CAGR of 6.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Product Type, Distribution Channel, Application, End-User, Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck Group, Bayer AG, CSL Behring, Baxter International Inc., Intas Pharmaceuticals Ltd., Octapharma AG, Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kedrion Biopharma Inc., Biotest AG, Sanquin, Taj Pharmaceuticals Limited, Kamada Pharmaceuticals, Bharat Serums and Vaccines Limited, Saol Therapeutics Inc., Aetos Pharma Private Limited, Avin Darou, PV Pharma Healthcare Pvt. Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Ocean Pharmacoat Pvt. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Anti-D Immunoglobulin Market Characteristics

3. Anti-D Immunoglobulin Market Trends And Strategies

4. Anti-D Immunoglobulin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Anti-D Immunoglobulin Growth Analysis And Strategic Analysis Framework

5.1. Global Anti-D Immunoglobulin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Anti-D Immunoglobulin Market Growth Rate Analysis

5.4. Global Anti-D Immunoglobulin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Anti-D Immunoglobulin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Anti-D Immunoglobulin Total Addressable Market (TAM)

6. Anti-D Immunoglobulin Market Segmentation

6.1. Global Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intramuscular Anti-D Immunoglobulin

Intravenous Anti-D Immunoglobulin

6.2. Global Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Other Distribution Channels

6.3. Global Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hemolytic Disease Of The Newborn

Immune Thrombocytopenic Purpura

Antenatal And Postnatal Prophylaxis

Other Applications

6.4. Global Anti-D Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Blood Banks

Research Laboratories

6.5. Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intramuscular Anti-D Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Standard Dose

High Dose

Pre-Filled Syringes

Vials

6.6. Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intravenous Anti-D Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lyophilized Powder

Liquid Formulation

Single-Use Vials

Multi-Dose Vials

7. Anti-D Immunoglobulin Market Regional And Country Analysis

7.1. Global Anti-D Immunoglobulin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Anti-D Immunoglobulin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anti-D Immunoglobulin Market

8.1. Asia-Pacific Anti-D Immunoglobulin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anti-D Immunoglobulin Market

9.1. China Anti-D Immunoglobulin Market Overview

9.2. China Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anti-D Immunoglobulin Market

10.1. India Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anti-D Immunoglobulin Market

11.1. Japan Anti-D Immunoglobulin Market Overview

11.2. Japan Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anti-D Immunoglobulin Market

12.1. Australia Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anti-D Immunoglobulin Market

13.1. Indonesia Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anti-D Immunoglobulin Market

14.1. South Korea Anti-D Immunoglobulin Market Overview

14.2. South Korea Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anti-D Immunoglobulin Market

15.1. Western Europe Anti-D Immunoglobulin Market Overview

15.2. Western Europe Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anti-D Immunoglobulin Market

16.1. UK Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anti-D Immunoglobulin Market

17.1. Germany Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anti-D Immunoglobulin Market

18.1. France Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anti-D Immunoglobulin Market

19.1. Italy Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anti-D Immunoglobulin Market

20.1. Spain Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anti-D Immunoglobulin Market

21.1. Eastern Europe Anti-D Immunoglobulin Market Overview

21.2. Eastern Europe Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anti-D Immunoglobulin Market

22.1. Russia Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anti-D Immunoglobulin Market

23.1. North America Anti-D Immunoglobulin Market Overview

23.2. North America Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anti-D Immunoglobulin Market

24.1. USA Anti-D Immunoglobulin Market Overview

24.2. USA Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anti-D Immunoglobulin Market

25.1. Canada Anti-D Immunoglobulin Market Overview

25.2. Canada Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anti-D Immunoglobulin Market

26.1. South America Anti-D Immunoglobulin Market Overview

26.2. South America Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anti-D Immunoglobulin Market

27.1. Brazil Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anti-D Immunoglobulin Market

28.1. Middle East Anti-D Immunoglobulin Market Overview

28.2. Middle East Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anti-D Immunoglobulin Market

29.1. Africa Anti-D Immunoglobulin Market Overview

29.2. Africa Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anti-D Immunoglobulin Market Competitive Landscape And Company Profiles

30.1. Anti-D Immunoglobulin Market Competitive Landscape

30.2. Anti-D Immunoglobulin Market Company Profiles

30.2.1. Merck Group Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Anti-D Immunoglobulin Market Other Major And Innovative Companies

31.1. Octapharma AG

31.2. Zydus Lifesciences Limited

31.3. Emergent BioSolutions Inc.

31.4. Kedrion Biopharma Inc.

31.5. Biotest AG

31.6. Sanquin

31.7. Taj Pharmaceuticals Limited

31.8. Kamada Pharmaceuticals

31.9. Bharat Serums and Vaccines Limited

31.10. Saol Therapeutics Inc.

31.11. Aetos Pharma Private Limited

31.12. Avin Darou

31.13. PV Pharma Healthcare Pvt. Ltd.

31.14. Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.

31.15. Ocean Pharmacoat Pvt. Ltd.

32. Global Anti-D Immunoglobulin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anti-D Immunoglobulin Market

34. Recent Developments In The Anti-D Immunoglobulin Market

35. Anti-D Immunoglobulin Market High Potential Countries, Segments and Strategies

35.1 Anti-D Immunoglobulin Market In 2029 - Countries Offering Most New Opportunities

35.2 Anti-D Immunoglobulin Market In 2029 - Segments Offering Most New Opportunities

35.3 Anti-D Immunoglobulin Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Anti-D Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intramuscular Anti-D Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intravenous Anti-D Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Anti-D Immunoglobulin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Anti-D Immunoglobulin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Merck Group Financial Performance
  • Table 78: Bayer AG Financial Performance
  • Table 79: CSL Behring Financial Performance
  • Table 80: Baxter International Inc. Financial Performance
  • Table 81: Intas Pharmaceuticals Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Anti-D Immunoglobulin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intramuscular Anti-D Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Anti-D Immunoglobulin Market, Sub-Segmentation Of Intravenous Anti-D Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Anti-D Immunoglobulin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Anti-D Immunoglobulin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Anti-D Immunoglobulin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Anti-D Immunoglobulin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Anti-D Immunoglobulin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Merck Group Financial Performance
  • Figure 78: Bayer AG Financial Performance
  • Figure 79: CSL Behring Financial Performance
  • Figure 80: Baxter International Inc. Financial Performance
  • Figure 81: Intas Pharmaceuticals Ltd. Financial Performance

Frequently Asked Questions

Anti-D immunoglobulin is a specialized blood product derived from human plasma that contains antibodies against the RhD antigen found on red blood cells. It is produced by collecting plasma from donors who have been sensitized to the RhD antigen, followed by purification and concentration of the specific immunoglobulin G (IgG) antibodies. For further insights on the Anti D Immunoglobulin market, request a sample here

The Anti D Immunoglobulin market major growth driver - Rise In Global Birth Rates Fueling The Growth Of The Market Due To Increasing Risk Of Rh Incompatibility. For further insights on the Anti D Immunoglobulin market, request a sample here

The Anti D Immunoglobulin market size has grown strongly in recent years. The anti-D immunoglobulin market size has grown strongly in recent years. It will grow from $2.42 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing awareness of rhesus incompatibility risks, expanding national immunization programs, implementation of maternal and neonatal health policies, rising global birth rates, and growth in blood transfusion procedures. The anti-D immunoglobulin market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising demand for antenatal and perinatal care, growing emphasis on maternal health in low- and middle-income countries, increasing healthcare infrastructure investments, expansion of universal health coverage programs, and regulatory support for immunoglobulin therapies. Major trends in the forecast period include advancements in plasma fractionation technology, development of recombinant antibody alternatives, increasing automation in immunoglobulin production, adoption of high-purity formulation techniques, and integration of cold chain monitoring systems. For further insights on the Anti D Immunoglobulin market, request a sample here

The anti-d immunoglobulin market covered in this report is segmented –
1) By Product Type: Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel
3) By Application: Hemolytic Disease Of The Newborn, Immune Thrombocytopenic Purpura, Antenatal And Postnatal Prophylaxis, Other Applications
4) By End-User: Hospitals, Clinics, Blood Banks, Research Laboratories Subsegments:
1) By Intramuscular Anti-D Immunoglobulin: Standard Dose, High Dose, Pre-Filled Syringes, Vials
2) By Intravenous Anti-D Immunoglobulin: Lyophilized Powder, Liquid Formulation, Single-Use Vials, Multi-Dose Vials For further insights on the Anti D Immunoglobulin market,
request a sample here

North America was the largest region in the anti-D immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-d immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Anti D Immunoglobulin market, request a sample here.

Major companies operating in the anti-d immunoglobulin market are Merck Group, Bayer AG, CSL Behring, Baxter International Inc., Intas Pharmaceuticals Ltd., Octapharma AG, Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kedrion Biopharma Inc., Biotest AG, Sanquin, Taj Pharmaceuticals Limited, Kamada Pharmaceuticals, Bharat Serums and Vaccines Limited, Saol Therapeutics Inc., Aetos Pharma Private Limited, Avin Darou, PV Pharma Healthcare Pvt. Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Ocean Pharmacoat Pvt. Ltd. . For further insights on the Anti D Immunoglobulin market, request a sample here.

Major trends in the Anti D Immunoglobulin market include Recombinant Innovation Enhances Rh Prophylaxis And Maternal Health Outcomes Globally. For further insights on the Anti D Immunoglobulin market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon